Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging

Bragheto AM, Aristides M Bragheto, Aristides Manoel dos Santos Bragheto, Caserta N, Nelson Caserta, Nelson Marcio Gomes Caserta, Bahamondes L, Luis Bahamondes, Luís Bahamondes, Petta CA, Carlos Alberto Petta, Carlos A Petta
Contraception · 2007 · vol. 76(3) , pp. 195–199 · doi:10.1016/j.contraception.2007.05.091 · PMID:17707716 · W2055038924
Non-randomised trial OA: closed CC0 ⤵ 82 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study evaluated the effectiveness of levonorgestrel-releasing intrauterine systems in managing adenomyosis, a condition diagnosed and monitored using magnetic resonance imaging.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: This study was conducted to evaluate the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on adenomyotic lesions diagnosed and monitored by magnetic resonance imaging (MRI). STUDY DESIGN: LNG-IUS was inserted during menstrual bleeding in 29 women, 24 to 46 years of age, with MRI-diagnosed adenomyosis associated with menorrhagia and dysmenorrhea. Clinical evaluations were carried out at baseline and at 3 and 6 months postinsertion. MRI was performed at baseline and at 6 months postinsertion and was used to calculate junctional zone thickness (in mm), to define the junctional zone borders, to identify the presence of high-signal foci on T(2)-weighted images and to calculate uterine volume (in mL). RESULTS: A significant reduction of 24.2% in junctional zone thickness was observed (p<.0001); however, no significant decrease in uterine volume was observed (142.6 mL vs. 136.4 mL; p=.2077) between baseline and the 6-month evaluation. A significant decrease in pain score was observed at 3 and 6 months after insertion (p3 at 6 months of observation. At 3 months of use, the most common bleeding pattern was spotting, and at 6 months of observation, oligomenorrhea was the most common pattern observed, although spotting was present in one third of the women. CONCLUSIONS: The insertion of an LNG-IUS led to a reduction in pain and abnormal bleeding associated with adenomyosis. MRI was useful for monitoring response of adenomyotic lesions to the LNG-IUS.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Contraceptive Agents, Female Endometriosis Levonorgestrel Magnetic Resonance Imaging Magnetic Resonance Imaging Uterine Diseases Uterus Adult Adult Contraceptive Agents, Female Contraceptive Agents, Female Endometriosis Endometriosis Endometriosis Female Female Humans Humans Intrauterine Devices, Medicated Intrauterine Devices, Medicated

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (22)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:04:39.942088+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK